ExxonMobil (XOM)

Investing Cash Flow

-$6.32B

Quarterly · Period ending: · USD

XOM logo

XOM Investing Cash Flow

Latest reported-$6.32B
XOM Quarterly Cash from Investing (-$1.73B → -$6.32B)
High-resolution chart · PNG

XOM investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ExxonMobil Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-6,319,000,000
-5,945,000,000
-7,409,000,000
-8,479,000,000
-6,180,000,000
-4,135,000,000
-4,252,000,000
-6,240,000,000
-4,859,000,000
-4,571,000,000
-6,226,000,000
-4,279,000,000
-4,356,000,000
-4,925,000,000
-5,355,000,000
-2,378,000,000
-3,064,000,000
-3,945,000,000
-2,110,000,000
-3,054,000,000
-2,716,000,000
-2,355,000,000
-3,302,000,000
-3,709,000,000
-5,081,000,000
-6,367,000,000
-4,264,000,000
-6,150,000,000
-6,877,000,000
-5,793,000,000
-5,584,000,000
-3,907,000,000
-5,096,000,000
-1,859,000,000
-6,536,000,000
-2,555,000,000
-2,878,000,000
-3,761,000,000
-1,672,000,000
-3,235,000,000
-3,147,000,000
-4,349,000,000
-5,324,000,000
-5,657,000,000
-6,491,000,000
-6,352,000,000
-8,847,000,000
-7,645,000,000
-4,177,000,000
-6,306,000,000
-6,712,000,000
-8,942,000,000
-8,493,000,000
-10,054,000,000
-9,002,000,000
-7,492,000,000
-3,756,000,000
-5,351,000,000
-2,012,000,000
-4,296,000,000
-10,504,000,000
-5,353,000,000
-7,080,000,000
-6,879,000,000
-5,078,000,000
-5,167,000,000
-6,422,000,000
-6,284,000,000
-4,973,000,000
-4,740,000,000
-2,627,000,000
-4,104,000,000
-4,468,000,000
-4,300,000,000
337,000,000
-3,742,000,000
-3,085,000,000
-3,238,000,000
-3,466,000,000
-3,988,000,000
-3,273,000,000
-3,503,000,000
-2,891,000,000
-4,165,000,000
-2,128,000,000
-1,086,000,000
-3,890,000,000
-2,870,000,000
-6,569,000,000
-1,581,000,000
-3,136,000,000
-3,335,000,000
-3,636,000,000
-735,000,000
-2,233,000,000
-3,155,000,000
-3,133,000,000
-1,237,000,000
-2,266,000,000
-2,631,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.